2141-V11
2141-V11 is an anti-CD40 agonist antibody with enhanced binding to FcγRIIB. 2141-V11 results in effective tumor-specific T-cell responses in vivo. 2141-V11 can be used for the study of BCG-unresponsive non-muscle invasive bladder cancer[1].
Product Specifications
CAS Number
2923542-55-4
UNSPSC
12352203
Target
TNF Receptor
Related Pathways
Apoptosis
Applications
Cancer-programmed cell death
Field of Research
Cancer
References & Citations
[1]Juan C. Osorio, et al. Abstract CT203: Fc-optimized anti-CD40 agonist antibody 2141-V11 for BCG-unresponsive non-muscle invasive bladder cancer: Updates on phase 1 study clinical outcomes and biological correlatives Free. Cancer Res (2025) 85 (8_Supplement_2) : CT203.
Shipping Conditions
Room temperature
Scientific Category
Inhibitory Antibodies
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
127253-HRP 100 µL
GDF3 (Growth/Differentiation Factor 3, GDF-3, UNQ222/PRO248, KFS3, MCOP7, MCOPCB6) (HRP)
Sign In for Pricing
View Details